MRI time series modeling of MS lesion development

被引:29
作者
Meier, Dominik S. [1 ]
Guttmann, Charles R. G. [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol,Ctr Neurol Imaging, Boston, MA 02115 USA
关键词
brain morphometry; multiple sclerosis; time series analysis; quantitative MRI; lesion evolution;
D O I
10.1016/j.neuroimage.2006.04.181
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A mathematical model was applied to new lesion formation in multiple sclerosis, as apparent on frequent T2-weighted MRI. The pathophysiologically motivated two-process model comprises two opposing nonlinear self-limiting processes, intended to represent degenerative and reparatury. Processes, respectively, investigating T2 activity from a dynamic/temporal rather than a spatial/static perspective. Parametric maps were obtained from the model to characterize the MRI dynamics of lesion development, answering the questions of how long new T2 lesion activity persists, how much residual damage/hyperintensity remains and how the T2 dynamics compare to those of contrastenhancing MRI indicating active inflammation. 997 MRI examinations were analyzed, acquired weekly to monthly from 45 patients over a 1-year period. The model was applied to all pixels within 332 new lesions, capturing the time profiles with excellent fidelity (r = 0.89 +/- 0.03 average correlation between model and image data). From this modeling perspective, the observed dynamics in new T2 lesions are in agreement with two opposing processes of longitudinal intensity change, such as inflammation and degeneration versus resorbtion and repair. On average, about one third of a new lesion consisted of transient signal change with little or no residual hyperintensity and activity, of 10 weeks or less. Global lesion burden as MRI surrogate of disease activity may therefore be confounded by large amounts of transient hyperintensity. T2 activity also persisted significantly beyond the period of contrast enhancement, thereby defining MRI sensitivity toward a subacute phase of lesion development beyond blood-brain barrier patency. Concentric patterns of dynamic properties within a lesion were observed, consistent with Concentric histological appearance of resulting MS plaques. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:531 / 537
页数:7
相关论文
共 20 条
[1]   Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years [J].
Bagnato, F ;
Jeffries, N ;
Richert, ND ;
Stone, RD ;
Ohayon, JM ;
McFarland, HF ;
Frank, JA .
BRAIN, 2003, 126 :1782-1789
[2]   Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance [J].
Barkhof, F ;
Brück, W ;
De Groot, CJA ;
Bergers, E ;
Hulshof, S ;
Geurts, J ;
Polman, CH ;
van der Valk, P .
ARCHIVES OF NEUROLOGY, 2003, 60 (08) :1073-1081
[3]   Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients [J].
Chen, JT ;
Collins, DL ;
Freedman, MS ;
Atkins, HL ;
Arnold, DL .
NEUROIMAGE, 2005, 25 (04) :1272-1278
[4]   MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals [J].
Cotton, F ;
Weiner, HL ;
Jolesz, FA ;
Guttmann, CRG .
NEUROLOGY, 2003, 60 (04) :640-646
[5]   Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis [J].
Filippi, M ;
Horsfield, MA ;
Tofts, PS ;
Barkhof, F ;
Thompson, AJ ;
Miller, DH .
BRAIN, 1995, 118 :1601-1612
[6]   A serial study of new MS lesions and the white matter from which they arise [J].
Goodkin, DE ;
Rooney, WD ;
Sloan, R ;
Bacchetti, P ;
Gee, L ;
Vermathen, M ;
Waubant, E ;
Abundo, M ;
Majumdar, S ;
Nelson, S ;
Weiner, MW .
NEUROLOGY, 1998, 51 (06) :1689-1697
[7]  
GUTTMANN CRG, 1995, AM J NEURORADIOL, V16, P1481
[8]   Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].
Jacobs, LD ;
Cookfair, DL ;
Rudick, RA ;
Herndon, RM ;
Richert, JR ;
Salazar, AM ;
Fischer, JS ;
Goodkin, DE ;
Granger, CV ;
Simon, JH ;
Alam, JJ ;
Bartoszak, DM ;
Bourdette, DN ;
Braiman, J ;
Brownscheidle, CM ;
Coats, ME ;
Cohan, SL ;
Dougherty, DS ;
Kinkel, RP ;
Mass, MK ;
Munschauer, FE ;
Priore, RL ;
Pullicino, PM ;
Scherokman, BJ ;
WeinstockGuttman, B ;
Whitman, RH ;
Baird, WC ;
Fillmore, M ;
Bona, LM ;
ColonRuiz, ME ;
Nadine, BS ;
Donovan, A ;
Bennett, S ;
Kieffer, YM ;
Umhauer, MA ;
Miller, CE ;
Kilic, AK ;
Sargent, EL ;
Schachter, M ;
Shucard, DW ;
Weider, V ;
Catalano, BA ;
Cervi, JM ;
Czekay, C ;
Farrell, JL ;
Filippini, JS ;
Matyas, RC ;
Michienzi, KE ;
Ito, M ;
OMalley, JA .
ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294
[9]  
Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO
[10]  
2-P